After a seven-year hiatus from football because of a life-changing injury, Shazier returns to his former team.

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers have investigated this with promising results. For the first time, it was possible to identify patient ...

The spinal cord stimulation technology from Swiss company Onward, called ARC-E-X, helps paralyzed people regain some mobility ...

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

For years, options for recovery have been limited, but a newly FDA-cleared external spinal stimulator, ARC-EX Therapy, which ...

The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

Researchers have demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic ...

New CEOs of Shepherd Center and Access to Capital for Entrepreneurs are marking their organizations' milestone birthdays with expansion and fundraising.

The latest study results have been published online in the renowned "The Lancet Neurology" journal. A multi-centre clinical trial (NISCI trial: Nogo-A Inhibition in acute Spinal Cord Injury Study) ...

Life can change in the blink of an eye. For Alix Schneider, this reality struck during a routine day when an unpredict ...

Your body is one of the most complex natural structures ever. Billions of cells are put together in a specific way with the ...